Tel: +44 (0) 1904 406082

Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.

Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.

We also supply nucleic acid lateral flow immunoassays and antibodies. Learn more:

Seralite® – FLC Serum

Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.

Read More

Seralite® – FLC Urine

Seralite®– FLC Urine* is a rapid lateral flow test for the qualitative in […]

Read More

Lateral flow assay reagents

A key element of any lateral flow assay development project is the […]

Read More

Nucleic acid lateral flow immunoassays

Abingdon Health manufactures nucleic acid lateral flow immunoassays (NALFIA), called PCRD and PCRD FLEX,

Read More

Clinical Utility

Clinicians are able to better understand disease status and can make informed decisions quickly and efficiently.

Read More

Technical Support

Contact us for sales assistance, technical support and further product information.

Read More